Logo image
457: Labor induction at 38 weeks versus expectant management of insulin-requiring diabetics in pregnancy: a cost effective analysis
Abstract   Peer reviewed

457: Labor induction at 38 weeks versus expectant management of insulin-requiring diabetics in pregnancy: a cost effective analysis

Unzila Nayeri, Sammy Tabbah, Erika Werner, Christian Pettker, Mark Landon and Stephen Thung
American journal of obstetrics and gynecology, Vol.210(1 Suppl), pp.S230-S230
12/21/2013
DOI: 10.1016/j.ajog.2013.10.490

View Online

Abstract

Objective Currently, there is no uniform recommendation for timing of delivery in pregnant patients with insulin-requiring diabetes mellitus (DM). The objective of this study was to determine if labor induction at 38 weeks gestation is cost effective when compared to expectant management. Study Design We developed a decision analysis model to compare the cost effectiveness of two strategies during pregnancy in women with insulin-requiring DM: (1) expectant management (EM) and (2) induction of labor at 38 weeks gestation (IOL). We considered risks of cesarean delivery (CD), preeclampsia, neonatal respiratory distress (RDS) and chronic lung disease (CLD), stillbirth (IUFD), neonatal demise (NND), shoulder dystocia (SD), and transient and permanent brachial plexus injuries (BPI). We assumed that the risk of CD was similar for both strategies, as previously demonstrated by a randomized trial, and that the risk of SD was lower with IOL (1.4% versus 3%). The main outcome measure was incremental cost-effectiveness ratio (ICER) defined as marginal cost per quality-adjusted life year (QALY) gained. An ICER <$100,000/QALY gained was considered cost effective. Sensitivity analyses and Monte Carlo simulations were performed. Results Our model demonstrates that for every 100,000 pregnancies complicated by insulin-requiring DM, IOL at 38 weeks results in an additional 100 QALYs gained at a cost of $2,069,000, which translates to an ICER of $20,069/QALY gained. For every 100,000 pregnancies, IOL at 38 weeks would prevent 42 IUFD and 14 permanent BPI and would result in an additional 9 NND and 100 CLD. The model remains robust in univariate sensitivity analyses. The model is most sensitive to probabilities of NND, RDS, and SD. Monte Carlo simulation demonstrates that IOL is either the dominant or more cost effective strategy 87% of the time. Conclusion In pregnant patients with insulin-requiring DM, induction of labor at 38 weeks is the cost effective strategy under a wide range of circumstances.

Details

Metrics

1 Record Views
Logo image